SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (596)11/26/2001 7:55:19 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3559
 
Monday November 26, 8:08 am Eastern Time
Press Release
SOURCE: Regeneron Pharmaceuticals, Inc.
Regeneron Announces Presentation at the Robertson Stephens Medical Conference
TARRYTOWN, N.Y.--(BW HealthWire)--Nov. 26, 2001--Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN - news) announced today that its presentation at the Robertson Stephens Medical Conference will be available through Regeneron's website.

Leonard Schleifer, M.D., Ph.D., Regeneron's President and Chief Executive Officer, will provide an overview of the Company and update its clinical programs including an update on the on-going Phase III AXOKINE® program. <snip>

Old news!